Patent US5897569A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4097601A Expired / Lapsed US ⏱️ 0.0 years remaining

Bone deposition by 2-descarboxy-2-(tetrazol-5-yl)-11-dexosy-16-aryl prostaglandins

Assignee: Pfizer Inc
•
Filing: 1977-08-26
•
Granted: 1978-06-27
•
Expires: 1997-08-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Bone deposition in animals is produced by administration of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-16-aryl-ω-tetranor prostaglandins of the E series, their C-15 keto isomers, and the pharmaceutically acceptable salts thereof.

Inventors

  • 👤 Thomas Ken Schaaf

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 11:23
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/557; A61K31/33; A61K31/395; A61K31/41

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 82 words
In the treatment of bone disorders, a method to increase the amount of both the osteomineral deposit and the osteoid present within bone by administration to a subject in need of said treatment an effective amount of a prostaglandin having the structure ##STR3## or the pharmacologically acceptable salts thereof wherein: A is ethylene or cis-vinylene: M is oxo, ##STR4## R is hydrogen or methyl; and Ar is phenyl or monosubstituted phenyl, said monosubstituent being fluoro, chloro, bromo, trifluoromethyl, methyl, methoxy and phenyl.
Claim 2
Dependent Claim 82 words
In the treatment of bone disorders, a method to increase the amount of both the osteomineral deposit and the osteoid present within bone by administration to a subject in need of said treatment an effective amount of a prostaglandin having the structure ##STR3## or the pharmacologically acceptable salts thereof wherein: A is ethylene or cis-vinylene: M is oxo, ##STR4## R is hydrogen or methyl; and Ar is phenyl or monosubstituted phenyl, said monosubstituent being fluoro, chloro, bromo, trifluoromethyl, methyl, methoxy and phenyl.
Claim 3
Dependent Claim 20 words
A method according to claim 1 wherein M of said prostaglandin is oxo, R is hydrogen and Ar is phenyl.
Claim 4
Dependent Claim 20 words
A method according to claim 1 wherein M of said prostaglandin is ##STR5## R is hydrogen and Ar is phenyl.
Claim 5
Dependent Claim 17 words
A method according to claim 2 wherein the magnesium salt of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-keto-16-phenyl-ω-tetranor prostaglandin E 0 is administered.
Claim 6
Dependent Claim 59 words
A method according to claim 1 wherein said bone disorder is osteopenia including osteoporosis, osteomalacia, osteitis fibrosa cystica and osteolysis; a pathological change in the dynamic balance of the blood serum calcium and bone calcium levels; peridontal disease; a fracture and said treatment enhances the healing rate of said fracture or bone loss associated with osteogenic carcinomas and tumors.
Claim 7
Dependent Claim 74 words
A method according to claim 1 wherein said prostaglandin is administered orally in a suspension or solution with water, ethyl alcohol or vegetable oil or administered orally in tablet or capsule form alone or in combination with excipients, binders and solid diluents such as corn starch, talc, gum arabic acacia, polyvinylpyrrolidone, clay, lactose, sucrose or dextrose at doses containing 2 microgram/kg to 0.2 milligrams/kg of said prostaglandin with up to 5 doses per day.
Claim 8
Dependent Claim 52 words
A method according to claim 1 wherein said prostaglandin is administered by injection intramuscularly, intravenously or subcutaneoulsy in a sterile mixture or solution with such diluents as normal saline or water and ethyl alcohol at doses containing 0.5 microgram/kg to 50 micrograms/kg of said prostaglandin with up to 5 doses per day.

References Cited (Backward Citations)

US3932389A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-06-26 1981-12-26 1982-06-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-06-26 1985-12-26 1986-06-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-06-26 1989-12-26 1990-06-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag